Status:

COMPLETED

Acceptance and Commitment Therapy-based Lifestyle Counselling Programme for Early Psychosis on Physical Activity

Lead Sponsor:

Chinese University of Hong Kong

Collaborating Sponsors:

North District Hospital

Conditions:

Schizophrenia Spectrum and Other Psychotic Disorders

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This pilot randomized controlled trial aims to determine the feasibility, acceptability and preliminary effects of an Acceptance and Commitment Therapy-based Lifestyle Counselling Programme (ACT-LCP) ...

Detailed Description

Background: Three-quarters of deaths in psychotic patients are caused by Cardiometabolic Diseases (CMD), including but not limited to cardiac disease, diabetes, and stroke. Globally, the average life ...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • at least 18 years of age or above
  • able to understand the nature of the study and give informed consent,
  • able to communicate in Cantonese,
  • have a diagnosis of psychotic disorders (e.g., delusional/brief psychotic disorder, schizotypal disorder, and psychosis not otherwise specified) according to the DSM IV-TR, DSM-V or ICD-10, within 5 years of onset as documented in their clinical/written records;
  • insufficiently active (i.e., \<150 minutes of MVPA per week) based on self-reports in a brief screening form, and
  • having used mobile instant-messaging apps (e.g. WhatsApp/Facebook messenger/WeChat) installed on a smartphone.
  • Exclusion criteria:
  • have had a record of alcohol abuse and/or substance misuse,
  • poor physical health condition, acute/severe medical diseases seriously reducing their life expectancy or ability to participate,
  • pregnancy or within six months of postpartum,
  • have received (within the past 6 months) or are receiving other physical and psychosocial interventions, and
  • severe psychiatric symptoms appeared in the past month.

Exclusion

    Key Trial Info

    Start Date :

    June 14 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    February 28 2024

    Estimated Enrollment :

    72 Patients enrolled

    Trial Details

    Trial ID

    NCT04916496

    Start Date

    June 14 2021

    End Date

    February 28 2024

    Last Update

    June 20 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Department of Psychiatry, North District Hospital

    Sheung Shui, New Territories, Hong Kong